The Bismuth–Corlette classification system provides an anatomic description ... They often manifest as a concentric thickening of the bile duct, coupled with infiltration of the periductal ...

FGFR2 gene fusion is observed in approximately 14% of intrahepatic cholangiocarcinoma, which accounts for 15%-30% of all biliary tract cancers, according to Eisai, but drug options are limited.

The FDA approved a companion diagnostic to identify patients with biliary tract cancer eligible for treatment with ...

Revolutionizing biliary obstruction care, EUS & ERCP lead the way with insights from the 2024 American Society for ...

Background: The purpose of the present study was to define the differential diagnostic markers of benign and malignant bile duct strictures ... [14] To evaluate biliary strictures of undetermined ...

This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of ... This trial was done to find out if oxaliplatin and 5FU is useful for people ...

For one post on her Instagram page, di ogbonge actress say she bin undergo surgery to remove her gallbladder afta serious ...

AstraZeneca's checkpoint inhibitor Imfinzi has become the first immunotherapy to be approved by the FDA for biliary tract ... and small intestine (cholangiocarcinoma), while a quarter had ...

Temozolomide (TMZ)–levetiracetam (LEV) combination therapy in glioblastoma management is gradually becoming a mainstay treatment given its superior effect compared with TMZ monotherapy. While there ...

A similar effect has been postulated on the smooth muscles in the gastrointestinal tract. In this study ... account for the treatment of biliary colic. In our endoscopic unit GTN proved to be useful ...